{"gene":"CEND1","run_date":"2026-06-09T22:57:18","timeline":{"discoveries":[{"year":1995,"finding":"BM88/CEND1 is a neuron-specific integral membrane protein of approximately 22 kDa, composed of two polypeptide chains linked by disulfide bridges, not glycosylated, and associated with mitochondrial limiting membranes, endoplasmic reticulum, small vesicles, and synaptic densities in neurons.","method":"Western blot, immunopurification, electron microscopy, Triton X-114 phase separation, N-glycanase digestion, protease digestion","journal":"Journal of neuroscience research","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal biochemical methods (phase separation, glycanase digestion, EM) in a focused study establishing protein properties","pmids":["7616611"],"is_preprint":false},{"year":1991,"finding":"BM88/CEND1 is an integral membrane protein with at least one small extramembranous domain; it cannot be solubilized by phospholipase C, indicating it is not GPI-anchored, and is anchored via a polypeptide transmembrane chain.","method":"Immunopurification, hydrophobic chromatography, Triton X-114 phase separation, phospholipase C digestion, protease digestion, gel filtration, SDS-PAGE","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution-level biochemical characterization with multiple orthogonal methods in a single focused study","pmids":["1704420"],"is_preprint":false},{"year":1995,"finding":"Overexpression of BM88/CEND1 in Neuro-2a neuroblastoma cells promotes morphological differentiation (enhanced process outgrowth), slows cell division, and accelerates differentiation in the presence of agents such as sucrose and retinoic acid, including induction of neurofilament protein expression.","method":"Stable transfection, morphological analysis, neurofilament immunostaining, cell growth assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function in cell culture with multiple readouts, single lab","pmids":["7775480"],"is_preprint":false},{"year":2006,"finding":"BM88/CEND1 overexpression in Neuro-2a cells causes cell cycle arrest at the G0/G1 restriction point via increased p53 levels, accumulation of hypophosphorylated retinoblastoma protein (pRb), and decreased/cytoplasmic relocalization of cyclin D1; conversely, BM88 siRNA knockdown accelerates proliferation and impairs retinoic acid-induced differentiation.","method":"Stable transfection, BrdU incorporation, FACS, Western blot, immunofluorescence for cyclin D1 localization, RNA interference","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal gain- and loss-of-function with multiple orthogonal cell cycle readouts, replicated by subsequent studies","pmids":["16893893"],"is_preprint":false},{"year":2007,"finding":"BM88/CEND1 is downstream of the proneural gene Mash1 (forced Mash1 expression induces endogenous BM88), and BM88 is sufficient to drive spinal cord neural precursors to exit the cell cycle, down-regulate Notch1, and commit to neuronal differentiation; BM88 siRNA knockdown enhances cell cycle progression and impairs neuronal differentiation.","method":"Gain-of-function overexpression in chick spinal cord, siRNA knockdown, immunohistochemistry for neuronal markers and Notch1, BrdU incorporation","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo gain- and loss-of-function with pathway epistasis (Mash1→BM88→Notch1), replicated across labs","pmids":["17971443"],"is_preprint":false},{"year":2008,"finding":"BM88/CEND1 overexpression diminishes P2Y receptor-induced intracellular calcium mobilization from IP3-sensitive stores in both Neuro-2a and HeLa cells, and reduces C2-ceramide-induced calcium release and apoptosis; BM88 knockdown facilitates proliferation under both stimulating and non-stimulating conditions.","method":"Calcium imaging, stable transfection, siRNA knockdown, P2Y receptor pharmacology, C2-ceramide apoptosis assay","journal":"Neuropharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal gain- and loss-of-function with calcium imaging in two cell types, single lab","pmids":["19061903"],"is_preprint":false},{"year":2008,"finding":"Trichostatin A (HDAC inhibitor) specifically induces Cend1 transcription in neuronal (Neuro-2a) but not non-neuronal cells, and Cend1 knockdown alleviates both the anti-proliferative and differentiation effects of TSA, placing Cend1 downstream of HDAC activity in the neuronal differentiation program.","method":"TSA treatment, RT-PCR, siRNA knockdown, cell proliferation and differentiation assays","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis established by knockdown rescue, single lab","pmids":["18258204"],"is_preprint":false},{"year":2010,"finding":"Cend1 knockout mice show increased proliferation of cerebellar granule cell precursors, delayed radial granule cell migration, and impaired Purkinje cell differentiation, with altered expression of Patched1, cyclin D1, reelin, and BDNF, leading to motor coordination deficits.","method":"Cend1 knockout mouse generation, histology, BrdU incorporation, immunohistochemistry, motor behavior tests","journal":"Molecular and cellular neurosciences","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo knockout with multiple cellular and molecular readouts and functional behavioral phenotype","pmids":["20153830"],"is_preprint":false},{"year":2013,"finding":"BM88/Cend1 physically interacts with RanBPM (Ran-binding protein M); this tripartite complex with Dyrk1B affects cyclin D1 levels and cell cycle progression: RanBPM reverses BM88/Cend1-dependent or Dyrk1B-dependent cyclin D1 downregulation by stabilizing cyclin D1 in the nucleus, but co-expression of Cend1 reverts RanBPM-dependent Dyrk1B cytosolic retention and degradation, resulting in cyclin D1 destabilization.","method":"Co-immunoprecipitation, transient co-expression, BrdU incorporation, Western blot, subcellular fractionation","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus functional cell cycle readouts, single lab, multiple constructs tested","pmids":["24312406"],"is_preprint":false},{"year":2013,"finding":"Full-length Ahi1 (but not N-terminal fragments) binds Hap1A in a phosphorylation-regulated manner, and also binds Cend1 as identified by mass spectrometry of cytosolic Ahi1 immunoprecipitates; Ahi1 loss reduces Cend1 protein levels in hypothalamus of Ahi1 KO mice, and overexpressed Ahi1 stabilizes Cend1 in cultured cells; Cend1 overexpression rescues neurite extension defects in hypothalamic neurons from Ahi1 KO mice.","method":"Mass spectrometry of immunoprecipitates, Western blot, overexpression rescue, Ahi1 KO mouse analysis, neurite extension assay","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — MS-identified interaction confirmed by functional rescue, single lab","pmids":["23658157"],"is_preprint":false},{"year":2015,"finding":"CEND1 is a key mediator of NEUROG2-driven neuronal reprogramming of mouse cortical astrocytes; knockdown of endogenous CEND1 impairs NEUROG2-driven neuronal conversion, and a reciprocal feedback loop exists between CEND1 and NEUROG2 at mRNA and protein levels.","method":"Lentiviral overexpression, siRNA knockdown, live-cell imaging, mRNA and protein expression analysis, immunocytochemistry","journal":"Stem cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with defined reprogramming phenotype plus epistasis to NEUROG2, single lab","pmids":["26321141"],"is_preprint":false},{"year":2019,"finding":"Expression of mammalian BM88/CEND1 in Drosophila reduces neuroblast and ganglion mother cell markers, impairs MP2 precursor formation, causes disorganized cell-cycle marker expression, disrupts eye disc development, and reduces activated MAP kinase (MAPK) levels, indicating functional interference with the MAPK signaling pathway.","method":"Transgenic Drosophila expression, immunohistochemistry for neuroblast/GMC markers, cell-cycle markers, anti-pMAP kinase Western blot","journal":"Neuroscience bulletin","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo gain-of-function in model organism with pathway readout (MAPK), single lab","pmids":["31079319"],"is_preprint":false},{"year":2005,"finding":"The BM88/CEND1 promoter contains four functional Sp1-binding sites that are required for activity; simultaneous mutation of all four Sp1 sites abolishes promoter activity. Neurogenin-1 also transactivates the BM88 promoter. An 88 bp minimal promoter fragment is sufficient for neuron-specific (but not glial) transcriptional activity.","method":"Promoter deletion analysis, site-directed mutagenesis of Sp1 sites, transactivation/reporter assays in primary neurons and glia","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — mutagenesis of regulatory elements with functional reporter readout, single lab","pmids":["16181419"],"is_preprint":false},{"year":2021,"finding":"Arhgef2 deficiency reduces Mettl14 expression and total m6A levels, decreasing m6A methylation of Cend1 mRNA; reduced m6A on Cend1 mRNA inhibits its nuclear export and translation, resulting in decreased CEND1 protein and impaired neuronal differentiation; overexpression of Cend1 rescues the neurogenesis defects of Arhgef2 KO mice.","method":"m6A sequencing, Arhgef2 knockout mice, mRNA nuclear export assays, Western blot, overexpression rescue","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — m6A-seq plus epistasis rescue in vivo, single lab","pmids":["34142067"],"is_preprint":false},{"year":2022,"finding":"CEND1 localizes to presynaptic mitochondria in neurons. CEND1 depletion increases mitochondrial fission via upregulation of Drp1, causing abnormal mitochondrial function and cognitive impairment. CDK5/p25 interacts with and phosphorylates CEND1, promoting its degradation. Overexpression of CEND1 in the hippocampus of 5xFAD mice rescues cognitive deficits.","method":"Proteomic analysis, subcellular fractionation/localization, Cend1 knockout/overexpression in mice, mitochondrial morphology assays, co-immunoprecipitation of CDK5/p25 with CEND1, phosphorylation assay, behavioral tests","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (localization, KO/OE, Co-IP, phosphorylation, behavior) in a single rigorous study","pmids":["35732922"],"is_preprint":false},{"year":2023,"finding":"LSD1 (a histone demethylase) epigenetically represses Cend1 transcription by maintaining low levels of H3K4me2 at the Cend1 promoter; loss of LSD1 in cardiomyocytes elevates H3K4me2 at the Cend1 promoter and increases Cend1 transcription, causing cell cycle arrest and heart growth defects; Cend1 knockdown rescues the proliferation defect caused by LSD1 inhibition, and genetic deletion of Cend1 rescues embryonic lethality of Lsd1 null mice.","method":"Cardiomyocyte-specific Lsd1 KO mice, RNA-seq, ChIP for H3K4me2, siRNA knockdown, Cend1/Lsd1 double KO mice, iPSC-derived cardiomyocytes","journal":"iScience","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — ChIP establishing epigenetic mechanism, reciprocal genetic epistasis in vivo, and human iPSC validation","pmids":["38226173"],"is_preprint":false},{"year":2025,"finding":"CEND1 forms homodimers via conserved GXXXA motifs in its transmembrane domain, and this dimerization is required to enhance ATP synthesis; disruption of dimerization (G130P mutation) destabilizes CEND1 and abolishes its ATP-enhancing effects. CEND1 physically interacts with Atp5f1b (mitochondrial ATP synthase subunit beta). The small molecule Tianeptine stabilizes CEND1 dimers and elevates ATP levels in a CEND1-dependent manner.","method":"CEND1 KO mice, co-immunoprecipitation/interaction assay for Atp5f1b, mutagenesis (G130P), ATP synthesis assays, mitochondrial membrane potential and mPTP assays, Tianeptine treatment with KO validation","journal":"Communications biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis of dimerization motif with functional ATP readout, interaction with Atp5f1b by Co-IP, in vivo KO validation; single lab but multiple orthogonal methods","pmids":["41469760"],"is_preprint":false},{"year":2025,"finding":"LSD1-dependent suppression of CEND1 is required for neonatal and adult heart regeneration; cardiomyocyte-specific Cend1 overexpression inhibits heart regeneration, while Cend1 nullizygous mice show enhanced cardiomyocyte proliferation, neovascularization, and macrophage activation; the cardiac regeneration defect from Lsd1 loss is rescued by Cend1 deletion.","method":"Cardiomyocyte-specific Lsd1 KO/OE mice, Cend1 null mice, cardiomyocyte-specific Cend1 OE mice, apical resection and LAD ligation injury models, RNA-seq, echocardiography, immunostaining","journal":"Theranostics","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal in vivo genetic epistasis (Lsd1 KO rescued by Cend1 KO) with multiple functional readouts, extends prior peer-reviewed findings","pmids":["40521201"],"is_preprint":false},{"year":2025,"finding":"CEND1 overexpression in glioma cells activates AMPK signaling, inhibits PDH activity and mitochondrial oxidative phosphorylation (reducing ATP levels), and induces cell cycle arrest and neuron-like morphology; CEND1 overexpression suppresses tumor growth in intracranial orthotopic mouse models.","method":"CEND1 overexpression in glioma cells, metabolomics, PDH activity assay, AMPK pathway Western blot, orthotopic tumor model","journal":"Cell & bioscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical and in vivo functional assays, single lab","pmids":["41239369"],"is_preprint":false}],"current_model":"CEND1/BM88 is a neuron-specific integral membrane protein that homodimerizes via GXXXA transmembrane motifs to support mitochondrial ATP synthesis through interaction with Atp5f1b; it acts as a cell cycle brake by promoting hypophosphorylation of pRb via cyclin D1 downregulation and p53 upregulation, operates downstream of proneural genes (Mash1, Neurogenin1/2) and HDAC activity, is epigenetically repressed by LSD1 (via H3K4me2), is post-translationally regulated by CDK5/p25-mediated phosphorylation and degradation, engages in a tripartite complex with RanBPM and Dyrk1B to modulate cyclin D1 stability, suppresses Notch1 and IP3-dependent calcium mobilization, and localizes to presynaptic mitochondria where its loss causes Drp1-mediated fission and mitochondrial dysfunction; collectively, these mechanisms coordinate cell cycle exit with neuronal differentiation during development and are relevant to neurodegeneration, cardiac development, and brain injury repair."},"narrative":{"mechanistic_narrative":"CEND1 (BM88) is a neuron-specific integral membrane protein that couples cell cycle exit to neuronal differentiation during development [PMID:7616611, PMID:16893893, PMID:17971443]. It acts as a cell-cycle brake: overexpression arrests cells at the G0/G1 restriction point through elevated p53, accumulation of hypophosphorylated pRb, and downregulation/cytoplasmic relocalization of cyclin D1, while its knockdown accelerates proliferation and impairs differentiation [PMID:16893893]. CEND1 operates within the proneural program, lying downstream of Mash1 and being sufficient to drive neural precursors out of the cycle, suppress Notch1, and commit to a neuronal fate [PMID:17971443]; it is similarly required for Neurogenin2-driven reprogramming of astrocytes [PMID:26321141]. Its expression is controlled at multiple levels—by Sp1 sites and Neurogenin1 at its promoter [PMID:16181419], downstream of HDAC activity [PMID:18258204], by LSD1-dependent H3K4me2 repression [PMID:38226173], and by m6A methylation that governs its mRNA export and translation [PMID:34142067]—and at the protein level through CDK5/p25-mediated phosphorylation and degradation [PMID:35732922] and stabilization by Ahi1 [PMID:23658157]. CEND1 modulates cyclin D1 stability within a tripartite complex with RanBPM and Dyrk1B [PMID:24312406] and dampens IP3-dependent calcium mobilization [PMID:19061903]. At presynaptic mitochondria, CEND1 homodimerizes through GXXXA transmembrane motifs and interacts with the ATP synthase subunit Atp5f1b to support ATP synthesis, with its loss driving Drp1-mediated fission and mitochondrial dysfunction [PMID:35732922, PMID:41469760]. Through these activities CEND1 functions are relevant to cerebellar development and motor coordination [PMID:20153830], cardiac development and heart regeneration where LSD1-dependent CEND1 suppression is required [PMID:38226173, PMID:40521201], glioma growth suppression via AMPK activation and inhibition of oxidative phosphorylation [PMID:41239369], and Alzheimer's-related cognitive deficits, where hippocampal CEND1 overexpression rescues 5xFAD mice [PMID:35732922].","teleology":[{"year":1991,"claim":"Established the basic biochemical nature of CEND1 before any function was known: whether it was a surface or intrinsic membrane protein and how it was anchored.","evidence":"Immunopurification, hydrophobic chromatography, Triton X-114 phase separation, and phospholipase C digestion of neuronal protein","pmids":["1704420"],"confidence":"High","gaps":["No topology of the extramembranous domain defined","No functional role established"]},{"year":1995,"claim":"Defined CEND1 as a ~22 kDa neuron-specific disulfide-linked dimeric membrane protein associated with mitochondria, ER, vesicles, and synaptic densities, anchoring later mitochondrial work.","evidence":"Western blot, immunopurification, electron microscopy, and glycanase/protease digestion in neurons","pmids":["7616611"],"confidence":"High","gaps":["Functional significance of multi-organelle localization unresolved","No molecular partners identified"]},{"year":1995,"claim":"First showed CEND1 has a cellular function by linking its overexpression to neuronal differentiation and slowed division.","evidence":"Stable transfection of Neuro-2a cells with morphological, neurofilament, and growth readouts","pmids":["7775480"],"confidence":"Medium","gaps":["Mechanism connecting CEND1 to differentiation not defined","Single cell line"]},{"year":2005,"claim":"Resolved how CEND1 transcription is restricted to neurons, identifying the cis-elements and a transactivator.","evidence":"Promoter deletion, Sp1-site mutagenesis, and reporter assays in primary neurons and glia","pmids":["16181419"],"confidence":"Medium","gaps":["Endogenous role of Neurogenin1 at the locus not tested in vivo","Single lab"]},{"year":2006,"claim":"Defined the molecular mechanism of CEND1's anti-proliferative effect via the p53/pRb/cyclin D1 axis using reciprocal gain- and loss-of-function.","evidence":"Stable transfection, siRNA, BrdU/FACS, and Western/IF for cell-cycle regulators in Neuro-2a","pmids":["16893893"],"confidence":"High","gaps":["Direct molecular target of CEND1 upstream of p53/cyclin D1 unknown","Cell-line based"]},{"year":2007,"claim":"Placed CEND1 in the proneural pathway in vivo (Mash1→CEND1→Notch1 suppression), establishing it as a node coupling cell-cycle exit to fate commitment.","evidence":"Gain/loss-of-function in chick spinal cord with neuronal-marker and Notch1 immunohistochemistry","pmids":["17971443"],"confidence":"High","gaps":["How CEND1 suppresses Notch1 mechanistically unknown","Direct vs indirect epistasis not resolved"]},{"year":2008,"claim":"Identified an additional CEND1 activity, dampening IP3-dependent calcium mobilization and ceramide-induced apoptosis.","evidence":"Calcium imaging with P2Y pharmacology and ceramide apoptosis assays in Neuro-2a and HeLa","pmids":["19061903"],"confidence":"Medium","gaps":["Molecular link between CEND1 and IP3 stores undefined","Single lab"]},{"year":2008,"claim":"Positioned CEND1 downstream of HDAC activity in the neuronal differentiation program.","evidence":"TSA treatment, RT-PCR, and knockdown rescue in neuronal vs non-neuronal cells","pmids":["18258204"],"confidence":"Medium","gaps":["Specific HDAC and direct chromatin mechanism not identified","Single lab"]},{"year":2010,"claim":"Demonstrated CEND1's developmental necessity in vivo through a knockout with cerebellar proliferation, migration, differentiation, and behavioral phenotypes.","evidence":"Cend1 knockout mice with histology, BrdU, immunohistochemistry, and motor tests","pmids":["20153830"],"confidence":"High","gaps":["Cell-autonomous vs non-autonomous contributions not fully separated","Molecular cause of altered Patched1/reelin/BDNF unclear"]},{"year":2013,"claim":"Revealed a protein-level mechanism for CEND1's control of cyclin D1 via a tripartite complex with RanBPM and Dyrk1B.","evidence":"Co-immunoprecipitation, transient co-expression, fractionation, and BrdU in cell culture","pmids":["24312406"],"confidence":"Medium","gaps":["Stoichiometry and direct binding interfaces not defined","Single Co-IP-based study"]},{"year":2013,"claim":"Showed CEND1 protein stability is regulated by Ahi1, linking it to neurite extension.","evidence":"Mass spectrometry of immunoprecipitates, Ahi1 KO mouse analysis, and overexpression rescue of neurite defects","pmids":["23658157"],"confidence":"Medium","gaps":["Direct vs indirect CEND1-Ahi1 interaction not resolved","Mechanism of stabilization unknown"]},{"year":2015,"claim":"Extended CEND1's role to direct reprogramming, showing it is required for NEUROG2-driven astrocyte-to-neuron conversion within a feedback loop.","evidence":"Lentiviral overexpression, siRNA, and live-cell imaging of reprogramming","pmids":["26321141"],"confidence":"Medium","gaps":["Molecular basis of the CEND1-NEUROG2 feedback unknown","Single lab"]},{"year":2019,"claim":"Connected CEND1 function to MAPK signaling using cross-species expression.","evidence":"Transgenic Drosophila expression with neuroblast/cell-cycle markers and anti-pMAPK Western blot","pmids":["31079319"],"confidence":"Medium","gaps":["Whether MAPK is a direct CEND1 target in mammals untested","Heterologous system"]},{"year":2021,"claim":"Identified m6A methylation of CEND1 mRNA as a post-transcriptional control point governing its export and translation during neurogenesis.","evidence":"m6A-seq, Arhgef2/Mettl14 knockout mice, export assays, and Cend1 overexpression rescue","pmids":["34142067"],"confidence":"Medium","gaps":["m6A reader mediating CEND1 export not identified","Single lab"]},{"year":2022,"claim":"Defined CEND1's mitochondrial role at presynaptic mitochondria and its post-translational regulation by CDK5/p25, linking it to Alzheimer's-related cognition.","evidence":"Proteomics, fractionation, KO/OE mice, Drp1 and mitochondrial assays, CDK5/p25 Co-IP and phosphorylation, and 5xFAD rescue","pmids":["35732922"],"confidence":"High","gaps":["How CEND1 restrains Drp1 mechanistically unresolved","CDK5 phosphosite mapping incomplete"]},{"year":2023,"claim":"Established LSD1-dependent H3K4me2 as the epigenetic mechanism repressing CEND1, with reciprocal genetic epistasis demonstrating CEND1 as the key downstream effector in cardiomyocyte proliferation.","evidence":"Cardiomyocyte Lsd1 KO mice, ChIP for H3K4me2, Lsd1/Cend1 double KO, and iPSC-derived cardiomyocytes","pmids":["38226173"],"confidence":"High","gaps":["Direct recruitment of LSD1 to the Cend1 promoter not detailed","Cardiac-specific generality unclear"]},{"year":2025,"claim":"Defined the structural basis of CEND1's mitochondrial activity: GXXXA-mediated homodimerization required for ATP-synthase interaction and ATP synthesis enhancement.","evidence":"CEND1 KO mice, Atp5f1b Co-IP, G130P dimerization mutant, ATP/mPTP assays, and Tianeptine stabilization","pmids":["41469760"],"confidence":"High","gaps":["Structure of the CEND1-Atp5f1b interface not solved","Single lab"]},{"year":2025,"claim":"Extended the LSD1-CEND1 axis to functional heart regeneration, showing CEND1 suppression is required and its deletion rescues Lsd1-loss defects.","evidence":"Cardiomyocyte Lsd1 and Cend1 genetic models, injury models, RNA-seq, echocardiography, and immunostaining","pmids":["40521201"],"confidence":"High","gaps":["Mechanistic link from CEND1 to neovascularization/macrophage activation unclear","Adult human relevance untested"]},{"year":2025,"claim":"Showed CEND1 suppresses glioma growth by activating AMPK and inhibiting oxidative phosphorylation, extending its tumor-suppressive metabolic role.","evidence":"CEND1 overexpression in glioma cells, metabolomics, PDH activity and AMPK Western blots, and orthotopic tumor model","pmids":["41239369"],"confidence":"Medium","gaps":["Direct molecular target driving AMPK activation undefined","Single lab"]},{"year":null,"claim":"How CEND1's plasma-membrane/ER cell-cycle activities are mechanistically integrated with its mitochondrial ATP-synthase function, and the direct molecular target through which it triggers p53/cyclin D1 and AMPK changes, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of CEND1 or its dimer-Atp5f1b interface","Direct effector linking CEND1 to p53/cyclin D1 unidentified","Unifying mechanism across cell-cycle and metabolic roles unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3,8,16]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,1,16]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,14,16]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[0]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,1]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[0]}],"pathway":[{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[3,4,15]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[4,7,10,17]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[16,18]}],"complexes":["CEND1 homodimer","CEND1-RanBPM-Dyrk1B complex"],"partners":["ATP5F1B","RANBPM","DYRK1B","CDK5","AHI1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q8N111","full_name":"Cell cycle exit and neuronal differentiation protein 1","aliases":["BM88 antigen"],"length_aa":149,"mass_kda":15.0,"function":"Involved in neuronal differentiation","subcellular_location":"Membrane","url":"https://www.uniprot.org/uniprotkb/Q8N111/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CEND1","classification":"Not Classified","n_dependent_lines":111,"n_total_lines":1208,"dependency_fraction":0.09188741721854304},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CEND1","total_profiled":1310},"omim":[{"mim_id":"608213","title":"CELL CYCLE EXIT AND NEURONAL DIFFERENTIATION 1; CEND1","url":"https://www.omim.org/entry/608213"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Mitochondria","reliability":"Approved"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":277.6}],"url":"https://www.proteinatlas.org/search/CEND1"},"hgnc":{"alias_symbol":["FLJ90066","BM88"],"prev_symbol":[]},"alphafold":{"accession":"Q8N111","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8N111","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8N111-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8N111-F1-predicted_aligned_error_v6.png","plddt_mean":60.78},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CEND1","jax_strain_url":"https://www.jax.org/strain/search?query=CEND1"},"sequence":{"accession":"Q8N111","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8N111.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8N111/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8N111"}},"corpus_meta":[{"pmid":"17971443","id":"PMC_17971443","title":"BM88/CEND1 coordinates cell cycle exit and differentiation of neuronal precursors.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17971443","citation_count":61,"is_preprint":false},{"pmid":"16893893","id":"PMC_16893893","title":"BM88 is a dual function molecule inducing cell cycle exit and neuronal differentiation of neuroblastoma cells via cyclin D1 down-regulation and retinoblastoma protein hypophosphorylation.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16893893","citation_count":51,"is_preprint":false},{"pmid":"35732922","id":"PMC_35732922","title":"CEND1 deficiency induces mitochondrial dysfunction and cognitive impairment in Alzheimer's disease.","date":"2022","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/35732922","citation_count":50,"is_preprint":false},{"pmid":"31191667","id":"PMC_31191667","title":"Cend1, a Story with Many Tales: From Regulation of Cell Cycle Progression/Exit of Neural Stem Cells to Brain Structure and Function.","date":"2019","source":"Stem cells international","url":"https://pubmed.ncbi.nlm.nih.gov/31191667","citation_count":35,"is_preprint":false},{"pmid":"19911428","id":"PMC_19911428","title":"Transplantation of embryonic neural stem/precursor cells overexpressing BM88/Cend1 enhances the generation of neuronal cells in the injured mouse cortex.","date":"2010","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/19911428","citation_count":34,"is_preprint":false},{"pmid":"15548196","id":"PMC_15548196","title":"BM88 is an early marker of proliferating precursor cells that will differentiate into the neuronal lineage.","date":"2004","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15548196","citation_count":33,"is_preprint":false},{"pmid":"7616611","id":"PMC_7616611","title":"Characterization and localization of the BM88 antigen in the developing and adult rat brain.","date":"1995","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/7616611","citation_count":30,"is_preprint":false},{"pmid":"26321141","id":"PMC_26321141","title":"CEND1 and NEUROGENIN2 Reprogram Mouse Astrocytes and Embryonic Fibroblasts to Induced Neural Precursors and Differentiated Neurons.","date":"2015","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26321141","citation_count":30,"is_preprint":false},{"pmid":"7775480","id":"PMC_7775480","title":"The BM88 antigen, a novel neuron-specific molecule, enhances the differentiation of mouse neuroblastoma cells.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7775480","citation_count":28,"is_preprint":false},{"pmid":"23658157","id":"PMC_23658157","title":"Loss of Ahi1 affects early development by impairing BM88/Cend1-mediated neuronal differentiation.","date":"2013","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23658157","citation_count":26,"is_preprint":false},{"pmid":"20153830","id":"PMC_20153830","title":"Impaired cerebellar development and deficits in motor coordination in mice lacking the neuronal protein BM88/Cend1.","date":"2010","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/20153830","citation_count":24,"is_preprint":false},{"pmid":"1704420","id":"PMC_1704420","title":"Purification and characterization of neuron-specific surface antigen defined by monoclonal antibody BM88.","date":"1991","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1704420","citation_count":22,"is_preprint":false},{"pmid":"24312406","id":"PMC_24312406","title":"Functional Interactions between BM88/Cend1, Ran-binding protein M and Dyrk1B kinase affect cyclin D1 levels and cell cycle progression/exit in mouse neuroblastoma cells.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24312406","citation_count":21,"is_preprint":false},{"pmid":"18258204","id":"PMC_18258204","title":"BM88/Cend1 is involved in histone deacetylase inhibition-mediated growth arrest and differentiation of neuroblastoma cells.","date":"2008","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/18258204","citation_count":20,"is_preprint":false},{"pmid":"16181419","id":"PMC_16181419","title":"Characterization of the BM88 promoter and identification of an 88 bp fragment sufficient to drive neurone-specific expression.","date":"2005","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16181419","citation_count":17,"is_preprint":false},{"pmid":"11311134","id":"PMC_11311134","title":"Cloning, expression and localization of human BM88 shows that it maps to chromosome 11p15.5, a region implicated in Beckwith-Wiedemann syndrome and tumorigenesis.","date":"2001","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/11311134","citation_count":16,"is_preprint":false},{"pmid":"16949349","id":"PMC_16949349","title":"Expression pattern of BM88 in the developing nervous system of the chick and mouse embryo.","date":"2006","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/16949349","citation_count":15,"is_preprint":false},{"pmid":"30760981","id":"PMC_30760981","title":"Increased Anxiety-Related Behavior, Impaired Cognitive Function and Cellular Alterations in the Brain of Cend1-deficient Mice.","date":"2019","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30760981","citation_count":14,"is_preprint":false},{"pmid":"20002527","id":"PMC_20002527","title":"C38, equivalent to BM88, is developmentally expressed in maturing retinal neurons and enhances neuronal maturation.","date":"2009","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20002527","citation_count":10,"is_preprint":false},{"pmid":"24526440","id":"PMC_24526440","title":"Downregulation of BM88 after optic nerve injury.","date":"2014","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/24526440","citation_count":9,"is_preprint":false},{"pmid":"9452316","id":"PMC_9452316","title":"Overexpression of the neuron-specific molecule BM88 in mouse neuroblastoma cells: altered responsiveness to growth factors.","date":"1998","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/9452316","citation_count":9,"is_preprint":false},{"pmid":"34549796","id":"PMC_34549796","title":"Cend1 and Neurog2 efficiently reprogram human cortical astrocytes to neural precursor cells and induced-neurons.","date":"2022","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34549796","citation_count":8,"is_preprint":false},{"pmid":"19061903","id":"PMC_19061903","title":"BM88/Cend1 regulates stimuli-induced intracellular calcium mobilization.","date":"2008","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19061903","citation_count":8,"is_preprint":false},{"pmid":"10715587","id":"PMC_10715587","title":"Early expression of the BM88 antigen during neuronal differentiation of P19 embryonal carcinoma cells.","date":"2000","source":"International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10715587","citation_count":8,"is_preprint":false},{"pmid":"34142067","id":"PMC_34142067","title":"Arhgef2 regulates neural differentiation in the cerebral cortex through mRNA m6A-methylation of Npdc1 and Cend1.","date":"2021","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/34142067","citation_count":8,"is_preprint":false},{"pmid":"37076051","id":"PMC_37076051","title":"Reperfusion-induced injury and the effects of the dithioacetate type hydrogen sulfide donor ibuprofen derivative, BM-88, in isolated rat hearts.","date":"2023","source":"European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37076051","citation_count":8,"is_preprint":false},{"pmid":"33027701","id":"PMC_33027701","title":"Interaction of CEND1 gene and life events in susceptibility to depressive symptoms in Chinese Han college students.","date":"2020","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/33027701","citation_count":5,"is_preprint":false},{"pmid":"31079319","id":"PMC_31079319","title":"Expression of Mammalian BM88/CEND1 in Drosophila Affects Nervous System Development by Interfering with Precursor Cell Formation.","date":"2019","source":"Neuroscience bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/31079319","citation_count":5,"is_preprint":false},{"pmid":"35045349","id":"PMC_35045349","title":"CEND1 and miR885 methylation changes associated with successful cognitive aging in community-dwelling older adults.","date":"2022","source":"Experimental gerontology","url":"https://pubmed.ncbi.nlm.nih.gov/35045349","citation_count":5,"is_preprint":false},{"pmid":"38226173","id":"PMC_38226173","title":"Epigenetic repression of Cend1 by lysine-specific demethylase 1 is essential for murine heart development.","date":"2023","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/38226173","citation_count":5,"is_preprint":false},{"pmid":"11356378","id":"PMC_11356378","title":"Cellular localization of BM88 mRNA in paraffin-embedded rat brain sections by combined immunohistochemistry and non-radioactive in situ hybridization.","date":"2001","source":"Brain research. Brain research protocols","url":"https://pubmed.ncbi.nlm.nih.gov/11356378","citation_count":4,"is_preprint":false},{"pmid":"37210647","id":"PMC_37210647","title":"Down-Regulation of CEND1 Expression Contributes to The Progression and Temozolomide Resistance of Glioma.","date":"2023","source":"Cell journal","url":"https://pubmed.ncbi.nlm.nih.gov/37210647","citation_count":3,"is_preprint":false},{"pmid":"40521201","id":"PMC_40521201","title":"Regulation of heart regeneration by LSD1 through suppressing CEND1.","date":"2025","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/40521201","citation_count":1,"is_preprint":false},{"pmid":"35728483","id":"PMC_35728483","title":"Research on the function of the Cend1 regulatory mechanism on p75NTR signaling in spinal cord injury.","date":"2022","source":"Neuropeptides","url":"https://pubmed.ncbi.nlm.nih.gov/35728483","citation_count":1,"is_preprint":false},{"pmid":"41469760","id":"PMC_41469760","title":"Targeting Cend1-Atp5f1b interaction rescues mitochondrial dysfunction and ameliorates ischemic brain injury.","date":"2025","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/41469760","citation_count":0,"is_preprint":false},{"pmid":"41239369","id":"PMC_41239369","title":"Neuronal differentiation regulator CEND1 coordinately suppresses tumor growth and energetics via AMPK signaling in brain glioma.","date":"2025","source":"Cell & bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/41239369","citation_count":0,"is_preprint":false},{"pmid":"41537354","id":"PMC_41537354","title":"Astragalus polysaccharide protects against neuron degeneration and mitochondrial dysfunction in Parkinson's disease by upregulating CEND1.","date":"2026","source":"Histology and histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/41537354","citation_count":0,"is_preprint":false},{"pmid":"41324177","id":"PMC_41324177","title":"[68Ga]Ga-DOTA-CEND1: A Novel PET Cyclic Peptide Tracer for Noninvasive Imaging of Neuropilin-1 Expression in Pan-Tumors.","date":"2025","source":"Molecular pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/41324177","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.09.14.676113","title":"BRCA2-deficiency Causes Global Transcriptomic Alterations in Endothelial Cells","date":"2025-09-17","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.14.676113","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":21885,"output_tokens":5001,"usd":0.070335,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":13177,"output_tokens":5231,"usd":0.09833,"stage2_stop_reason":"end_turn"},"total_usd":0.168665,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"BM88/CEND1 is a neuron-specific integral membrane protein of approximately 22 kDa, composed of two polypeptide chains linked by disulfide bridges, not glycosylated, and associated with mitochondrial limiting membranes, endoplasmic reticulum, small vesicles, and synaptic densities in neurons.\",\n      \"method\": \"Western blot, immunopurification, electron microscopy, Triton X-114 phase separation, N-glycanase digestion, protease digestion\",\n      \"journal\": \"Journal of neuroscience research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal biochemical methods (phase separation, glycanase digestion, EM) in a focused study establishing protein properties\",\n      \"pmids\": [\"7616611\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"BM88/CEND1 is an integral membrane protein with at least one small extramembranous domain; it cannot be solubilized by phospholipase C, indicating it is not GPI-anchored, and is anchored via a polypeptide transmembrane chain.\",\n      \"method\": \"Immunopurification, hydrophobic chromatography, Triton X-114 phase separation, phospholipase C digestion, protease digestion, gel filtration, SDS-PAGE\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution-level biochemical characterization with multiple orthogonal methods in a single focused study\",\n      \"pmids\": [\"1704420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Overexpression of BM88/CEND1 in Neuro-2a neuroblastoma cells promotes morphological differentiation (enhanced process outgrowth), slows cell division, and accelerates differentiation in the presence of agents such as sucrose and retinoic acid, including induction of neurofilament protein expression.\",\n      \"method\": \"Stable transfection, morphological analysis, neurofilament immunostaining, cell growth assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function in cell culture with multiple readouts, single lab\",\n      \"pmids\": [\"7775480\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"BM88/CEND1 overexpression in Neuro-2a cells causes cell cycle arrest at the G0/G1 restriction point via increased p53 levels, accumulation of hypophosphorylated retinoblastoma protein (pRb), and decreased/cytoplasmic relocalization of cyclin D1; conversely, BM88 siRNA knockdown accelerates proliferation and impairs retinoic acid-induced differentiation.\",\n      \"method\": \"Stable transfection, BrdU incorporation, FACS, Western blot, immunofluorescence for cyclin D1 localization, RNA interference\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal gain- and loss-of-function with multiple orthogonal cell cycle readouts, replicated by subsequent studies\",\n      \"pmids\": [\"16893893\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"BM88/CEND1 is downstream of the proneural gene Mash1 (forced Mash1 expression induces endogenous BM88), and BM88 is sufficient to drive spinal cord neural precursors to exit the cell cycle, down-regulate Notch1, and commit to neuronal differentiation; BM88 siRNA knockdown enhances cell cycle progression and impairs neuronal differentiation.\",\n      \"method\": \"Gain-of-function overexpression in chick spinal cord, siRNA knockdown, immunohistochemistry for neuronal markers and Notch1, BrdU incorporation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo gain- and loss-of-function with pathway epistasis (Mash1→BM88→Notch1), replicated across labs\",\n      \"pmids\": [\"17971443\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"BM88/CEND1 overexpression diminishes P2Y receptor-induced intracellular calcium mobilization from IP3-sensitive stores in both Neuro-2a and HeLa cells, and reduces C2-ceramide-induced calcium release and apoptosis; BM88 knockdown facilitates proliferation under both stimulating and non-stimulating conditions.\",\n      \"method\": \"Calcium imaging, stable transfection, siRNA knockdown, P2Y receptor pharmacology, C2-ceramide apoptosis assay\",\n      \"journal\": \"Neuropharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal gain- and loss-of-function with calcium imaging in two cell types, single lab\",\n      \"pmids\": [\"19061903\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Trichostatin A (HDAC inhibitor) specifically induces Cend1 transcription in neuronal (Neuro-2a) but not non-neuronal cells, and Cend1 knockdown alleviates both the anti-proliferative and differentiation effects of TSA, placing Cend1 downstream of HDAC activity in the neuronal differentiation program.\",\n      \"method\": \"TSA treatment, RT-PCR, siRNA knockdown, cell proliferation and differentiation assays\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis established by knockdown rescue, single lab\",\n      \"pmids\": [\"18258204\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Cend1 knockout mice show increased proliferation of cerebellar granule cell precursors, delayed radial granule cell migration, and impaired Purkinje cell differentiation, with altered expression of Patched1, cyclin D1, reelin, and BDNF, leading to motor coordination deficits.\",\n      \"method\": \"Cend1 knockout mouse generation, histology, BrdU incorporation, immunohistochemistry, motor behavior tests\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo knockout with multiple cellular and molecular readouts and functional behavioral phenotype\",\n      \"pmids\": [\"20153830\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"BM88/Cend1 physically interacts with RanBPM (Ran-binding protein M); this tripartite complex with Dyrk1B affects cyclin D1 levels and cell cycle progression: RanBPM reverses BM88/Cend1-dependent or Dyrk1B-dependent cyclin D1 downregulation by stabilizing cyclin D1 in the nucleus, but co-expression of Cend1 reverts RanBPM-dependent Dyrk1B cytosolic retention and degradation, resulting in cyclin D1 destabilization.\",\n      \"method\": \"Co-immunoprecipitation, transient co-expression, BrdU incorporation, Western blot, subcellular fractionation\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus functional cell cycle readouts, single lab, multiple constructs tested\",\n      \"pmids\": [\"24312406\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Full-length Ahi1 (but not N-terminal fragments) binds Hap1A in a phosphorylation-regulated manner, and also binds Cend1 as identified by mass spectrometry of cytosolic Ahi1 immunoprecipitates; Ahi1 loss reduces Cend1 protein levels in hypothalamus of Ahi1 KO mice, and overexpressed Ahi1 stabilizes Cend1 in cultured cells; Cend1 overexpression rescues neurite extension defects in hypothalamic neurons from Ahi1 KO mice.\",\n      \"method\": \"Mass spectrometry of immunoprecipitates, Western blot, overexpression rescue, Ahi1 KO mouse analysis, neurite extension assay\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — MS-identified interaction confirmed by functional rescue, single lab\",\n      \"pmids\": [\"23658157\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CEND1 is a key mediator of NEUROG2-driven neuronal reprogramming of mouse cortical astrocytes; knockdown of endogenous CEND1 impairs NEUROG2-driven neuronal conversion, and a reciprocal feedback loop exists between CEND1 and NEUROG2 at mRNA and protein levels.\",\n      \"method\": \"Lentiviral overexpression, siRNA knockdown, live-cell imaging, mRNA and protein expression analysis, immunocytochemistry\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with defined reprogramming phenotype plus epistasis to NEUROG2, single lab\",\n      \"pmids\": [\"26321141\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Expression of mammalian BM88/CEND1 in Drosophila reduces neuroblast and ganglion mother cell markers, impairs MP2 precursor formation, causes disorganized cell-cycle marker expression, disrupts eye disc development, and reduces activated MAP kinase (MAPK) levels, indicating functional interference with the MAPK signaling pathway.\",\n      \"method\": \"Transgenic Drosophila expression, immunohistochemistry for neuroblast/GMC markers, cell-cycle markers, anti-pMAP kinase Western blot\",\n      \"journal\": \"Neuroscience bulletin\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo gain-of-function in model organism with pathway readout (MAPK), single lab\",\n      \"pmids\": [\"31079319\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The BM88/CEND1 promoter contains four functional Sp1-binding sites that are required for activity; simultaneous mutation of all four Sp1 sites abolishes promoter activity. Neurogenin-1 also transactivates the BM88 promoter. An 88 bp minimal promoter fragment is sufficient for neuron-specific (but not glial) transcriptional activity.\",\n      \"method\": \"Promoter deletion analysis, site-directed mutagenesis of Sp1 sites, transactivation/reporter assays in primary neurons and glia\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis of regulatory elements with functional reporter readout, single lab\",\n      \"pmids\": [\"16181419\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Arhgef2 deficiency reduces Mettl14 expression and total m6A levels, decreasing m6A methylation of Cend1 mRNA; reduced m6A on Cend1 mRNA inhibits its nuclear export and translation, resulting in decreased CEND1 protein and impaired neuronal differentiation; overexpression of Cend1 rescues the neurogenesis defects of Arhgef2 KO mice.\",\n      \"method\": \"m6A sequencing, Arhgef2 knockout mice, mRNA nuclear export assays, Western blot, overexpression rescue\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — m6A-seq plus epistasis rescue in vivo, single lab\",\n      \"pmids\": [\"34142067\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CEND1 localizes to presynaptic mitochondria in neurons. CEND1 depletion increases mitochondrial fission via upregulation of Drp1, causing abnormal mitochondrial function and cognitive impairment. CDK5/p25 interacts with and phosphorylates CEND1, promoting its degradation. Overexpression of CEND1 in the hippocampus of 5xFAD mice rescues cognitive deficits.\",\n      \"method\": \"Proteomic analysis, subcellular fractionation/localization, Cend1 knockout/overexpression in mice, mitochondrial morphology assays, co-immunoprecipitation of CDK5/p25 with CEND1, phosphorylation assay, behavioral tests\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (localization, KO/OE, Co-IP, phosphorylation, behavior) in a single rigorous study\",\n      \"pmids\": [\"35732922\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"LSD1 (a histone demethylase) epigenetically represses Cend1 transcription by maintaining low levels of H3K4me2 at the Cend1 promoter; loss of LSD1 in cardiomyocytes elevates H3K4me2 at the Cend1 promoter and increases Cend1 transcription, causing cell cycle arrest and heart growth defects; Cend1 knockdown rescues the proliferation defect caused by LSD1 inhibition, and genetic deletion of Cend1 rescues embryonic lethality of Lsd1 null mice.\",\n      \"method\": \"Cardiomyocyte-specific Lsd1 KO mice, RNA-seq, ChIP for H3K4me2, siRNA knockdown, Cend1/Lsd1 double KO mice, iPSC-derived cardiomyocytes\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — ChIP establishing epigenetic mechanism, reciprocal genetic epistasis in vivo, and human iPSC validation\",\n      \"pmids\": [\"38226173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CEND1 forms homodimers via conserved GXXXA motifs in its transmembrane domain, and this dimerization is required to enhance ATP synthesis; disruption of dimerization (G130P mutation) destabilizes CEND1 and abolishes its ATP-enhancing effects. CEND1 physically interacts with Atp5f1b (mitochondrial ATP synthase subunit beta). The small molecule Tianeptine stabilizes CEND1 dimers and elevates ATP levels in a CEND1-dependent manner.\",\n      \"method\": \"CEND1 KO mice, co-immunoprecipitation/interaction assay for Atp5f1b, mutagenesis (G130P), ATP synthesis assays, mitochondrial membrane potential and mPTP assays, Tianeptine treatment with KO validation\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis of dimerization motif with functional ATP readout, interaction with Atp5f1b by Co-IP, in vivo KO validation; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"41469760\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"LSD1-dependent suppression of CEND1 is required for neonatal and adult heart regeneration; cardiomyocyte-specific Cend1 overexpression inhibits heart regeneration, while Cend1 nullizygous mice show enhanced cardiomyocyte proliferation, neovascularization, and macrophage activation; the cardiac regeneration defect from Lsd1 loss is rescued by Cend1 deletion.\",\n      \"method\": \"Cardiomyocyte-specific Lsd1 KO/OE mice, Cend1 null mice, cardiomyocyte-specific Cend1 OE mice, apical resection and LAD ligation injury models, RNA-seq, echocardiography, immunostaining\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal in vivo genetic epistasis (Lsd1 KO rescued by Cend1 KO) with multiple functional readouts, extends prior peer-reviewed findings\",\n      \"pmids\": [\"40521201\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CEND1 overexpression in glioma cells activates AMPK signaling, inhibits PDH activity and mitochondrial oxidative phosphorylation (reducing ATP levels), and induces cell cycle arrest and neuron-like morphology; CEND1 overexpression suppresses tumor growth in intracranial orthotopic mouse models.\",\n      \"method\": \"CEND1 overexpression in glioma cells, metabolomics, PDH activity assay, AMPK pathway Western blot, orthotopic tumor model\",\n      \"journal\": \"Cell & bioscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical and in vivo functional assays, single lab\",\n      \"pmids\": [\"41239369\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CEND1/BM88 is a neuron-specific integral membrane protein that homodimerizes via GXXXA transmembrane motifs to support mitochondrial ATP synthesis through interaction with Atp5f1b; it acts as a cell cycle brake by promoting hypophosphorylation of pRb via cyclin D1 downregulation and p53 upregulation, operates downstream of proneural genes (Mash1, Neurogenin1/2) and HDAC activity, is epigenetically repressed by LSD1 (via H3K4me2), is post-translationally regulated by CDK5/p25-mediated phosphorylation and degradation, engages in a tripartite complex with RanBPM and Dyrk1B to modulate cyclin D1 stability, suppresses Notch1 and IP3-dependent calcium mobilization, and localizes to presynaptic mitochondria where its loss causes Drp1-mediated fission and mitochondrial dysfunction; collectively, these mechanisms coordinate cell cycle exit with neuronal differentiation during development and are relevant to neurodegeneration, cardiac development, and brain injury repair.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CEND1 (BM88) is a neuron-specific integral membrane protein that couples cell cycle exit to neuronal differentiation during development [#0, #3, #4]. It acts as a cell-cycle brake: overexpression arrests cells at the G0/G1 restriction point through elevated p53, accumulation of hypophosphorylated pRb, and downregulation/cytoplasmic relocalization of cyclin D1, while its knockdown accelerates proliferation and impairs differentiation [#3]. CEND1 operates within the proneural program, lying downstream of Mash1 and being sufficient to drive neural precursors out of the cycle, suppress Notch1, and commit to a neuronal fate [#4]; it is similarly required for Neurogenin2-driven reprogramming of astrocytes [#10]. Its expression is controlled at multiple levels—by Sp1 sites and Neurogenin1 at its promoter [#12], downstream of HDAC activity [#6], by LSD1-dependent H3K4me2 repression [#15], and by m6A methylation that governs its mRNA export and translation [#13]—and at the protein level through CDK5/p25-mediated phosphorylation and degradation [#14] and stabilization by Ahi1 [#9]. CEND1 modulates cyclin D1 stability within a tripartite complex with RanBPM and Dyrk1B [#8] and dampens IP3-dependent calcium mobilization [#5]. At presynaptic mitochondria, CEND1 homodimerizes through GXXXA transmembrane motifs and interacts with the ATP synthase subunit Atp5f1b to support ATP synthesis, with its loss driving Drp1-mediated fission and mitochondrial dysfunction [#14, #16]. Through these activities CEND1 functions are relevant to cerebellar development and motor coordination [#7], cardiac development and heart regeneration where LSD1-dependent CEND1 suppression is required [#15, #17], glioma growth suppression via AMPK activation and inhibition of oxidative phosphorylation [#18], and Alzheimer's-related cognitive deficits, where hippocampal CEND1 overexpression rescues 5xFAD mice [#14].\",\n  \"teleology\": [\n    {\n      \"year\": 1991,\n      \"claim\": \"Established the basic biochemical nature of CEND1 before any function was known: whether it was a surface or intrinsic membrane protein and how it was anchored.\",\n      \"evidence\": \"Immunopurification, hydrophobic chromatography, Triton X-114 phase separation, and phospholipase C digestion of neuronal protein\",\n      \"pmids\": [\"1704420\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No topology of the extramembranous domain defined\", \"No functional role established\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Defined CEND1 as a ~22 kDa neuron-specific disulfide-linked dimeric membrane protein associated with mitochondria, ER, vesicles, and synaptic densities, anchoring later mitochondrial work.\",\n      \"evidence\": \"Western blot, immunopurification, electron microscopy, and glycanase/protease digestion in neurons\",\n      \"pmids\": [\"7616611\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional significance of multi-organelle localization unresolved\", \"No molecular partners identified\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"First showed CEND1 has a cellular function by linking its overexpression to neuronal differentiation and slowed division.\",\n      \"evidence\": \"Stable transfection of Neuro-2a cells with morphological, neurofilament, and growth readouts\",\n      \"pmids\": [\"7775480\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism connecting CEND1 to differentiation not defined\", \"Single cell line\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Resolved how CEND1 transcription is restricted to neurons, identifying the cis-elements and a transactivator.\",\n      \"evidence\": \"Promoter deletion, Sp1-site mutagenesis, and reporter assays in primary neurons and glia\",\n      \"pmids\": [\"16181419\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous role of Neurogenin1 at the locus not tested in vivo\", \"Single lab\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined the molecular mechanism of CEND1's anti-proliferative effect via the p53/pRb/cyclin D1 axis using reciprocal gain- and loss-of-function.\",\n      \"evidence\": \"Stable transfection, siRNA, BrdU/FACS, and Western/IF for cell-cycle regulators in Neuro-2a\",\n      \"pmids\": [\"16893893\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular target of CEND1 upstream of p53/cyclin D1 unknown\", \"Cell-line based\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Placed CEND1 in the proneural pathway in vivo (Mash1\\u2192CEND1\\u2192Notch1 suppression), establishing it as a node coupling cell-cycle exit to fate commitment.\",\n      \"evidence\": \"Gain/loss-of-function in chick spinal cord with neuronal-marker and Notch1 immunohistochemistry\",\n      \"pmids\": [\"17971443\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How CEND1 suppresses Notch1 mechanistically unknown\", \"Direct vs indirect epistasis not resolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified an additional CEND1 activity, dampening IP3-dependent calcium mobilization and ceramide-induced apoptosis.\",\n      \"evidence\": \"Calcium imaging with P2Y pharmacology and ceramide apoptosis assays in Neuro-2a and HeLa\",\n      \"pmids\": [\"19061903\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular link between CEND1 and IP3 stores undefined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Positioned CEND1 downstream of HDAC activity in the neuronal differentiation program.\",\n      \"evidence\": \"TSA treatment, RT-PCR, and knockdown rescue in neuronal vs non-neuronal cells\",\n      \"pmids\": [\"18258204\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific HDAC and direct chromatin mechanism not identified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrated CEND1's developmental necessity in vivo through a knockout with cerebellar proliferation, migration, differentiation, and behavioral phenotypes.\",\n      \"evidence\": \"Cend1 knockout mice with histology, BrdU, immunohistochemistry, and motor tests\",\n      \"pmids\": [\"20153830\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-autonomous vs non-autonomous contributions not fully separated\", \"Molecular cause of altered Patched1/reelin/BDNF unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Revealed a protein-level mechanism for CEND1's control of cyclin D1 via a tripartite complex with RanBPM and Dyrk1B.\",\n      \"evidence\": \"Co-immunoprecipitation, transient co-expression, fractionation, and BrdU in cell culture\",\n      \"pmids\": [\"24312406\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Stoichiometry and direct binding interfaces not defined\", \"Single Co-IP-based study\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Showed CEND1 protein stability is regulated by Ahi1, linking it to neurite extension.\",\n      \"evidence\": \"Mass spectrometry of immunoprecipitates, Ahi1 KO mouse analysis, and overexpression rescue of neurite defects\",\n      \"pmids\": [\"23658157\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect CEND1-Ahi1 interaction not resolved\", \"Mechanism of stabilization unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Extended CEND1's role to direct reprogramming, showing it is required for NEUROG2-driven astrocyte-to-neuron conversion within a feedback loop.\",\n      \"evidence\": \"Lentiviral overexpression, siRNA, and live-cell imaging of reprogramming\",\n      \"pmids\": [\"26321141\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular basis of the CEND1-NEUROG2 feedback unknown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Connected CEND1 function to MAPK signaling using cross-species expression.\",\n      \"evidence\": \"Transgenic Drosophila expression with neuroblast/cell-cycle markers and anti-pMAPK Western blot\",\n      \"pmids\": [\"31079319\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether MAPK is a direct CEND1 target in mammals untested\", \"Heterologous system\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identified m6A methylation of CEND1 mRNA as a post-transcriptional control point governing its export and translation during neurogenesis.\",\n      \"evidence\": \"m6A-seq, Arhgef2/Mettl14 knockout mice, export assays, and Cend1 overexpression rescue\",\n      \"pmids\": [\"34142067\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"m6A reader mediating CEND1 export not identified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Defined CEND1's mitochondrial role at presynaptic mitochondria and its post-translational regulation by CDK5/p25, linking it to Alzheimer's-related cognition.\",\n      \"evidence\": \"Proteomics, fractionation, KO/OE mice, Drp1 and mitochondrial assays, CDK5/p25 Co-IP and phosphorylation, and 5xFAD rescue\",\n      \"pmids\": [\"35732922\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How CEND1 restrains Drp1 mechanistically unresolved\", \"CDK5 phosphosite mapping incomplete\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Established LSD1-dependent H3K4me2 as the epigenetic mechanism repressing CEND1, with reciprocal genetic epistasis demonstrating CEND1 as the key downstream effector in cardiomyocyte proliferation.\",\n      \"evidence\": \"Cardiomyocyte Lsd1 KO mice, ChIP for H3K4me2, Lsd1/Cend1 double KO, and iPSC-derived cardiomyocytes\",\n      \"pmids\": [\"38226173\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct recruitment of LSD1 to the Cend1 promoter not detailed\", \"Cardiac-specific generality unclear\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Defined the structural basis of CEND1's mitochondrial activity: GXXXA-mediated homodimerization required for ATP-synthase interaction and ATP synthesis enhancement.\",\n      \"evidence\": \"CEND1 KO mice, Atp5f1b Co-IP, G130P dimerization mutant, ATP/mPTP assays, and Tianeptine stabilization\",\n      \"pmids\": [\"41469760\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of the CEND1-Atp5f1b interface not solved\", \"Single lab\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extended the LSD1-CEND1 axis to functional heart regeneration, showing CEND1 suppression is required and its deletion rescues Lsd1-loss defects.\",\n      \"evidence\": \"Cardiomyocyte Lsd1 and Cend1 genetic models, injury models, RNA-seq, echocardiography, and immunostaining\",\n      \"pmids\": [\"40521201\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanistic link from CEND1 to neovascularization/macrophage activation unclear\", \"Adult human relevance untested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Showed CEND1 suppresses glioma growth by activating AMPK and inhibiting oxidative phosphorylation, extending its tumor-suppressive metabolic role.\",\n      \"evidence\": \"CEND1 overexpression in glioma cells, metabolomics, PDH activity and AMPK Western blots, and orthotopic tumor model\",\n      \"pmids\": [\"41239369\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct molecular target driving AMPK activation undefined\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How CEND1's plasma-membrane/ER cell-cycle activities are mechanistically integrated with its mitochondrial ATP-synthase function, and the direct molecular target through which it triggers p53/cyclin D1 and AMPK changes, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of CEND1 or its dimer-Atp5f1b interface\", \"Direct effector linking CEND1 to p53/cyclin D1 unidentified\", \"Unifying mechanism across cell-cycle and metabolic roles unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 8, 16]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 1, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 14, 16]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [3, 4, 15]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [4, 7, 10, 17]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [16, 18]}\n    ],\n    \"complexes\": [\"CEND1 homodimer\", \"CEND1-RanBPM-Dyrk1B complex\"],\n    \"partners\": [\"Atp5f1b\", \"RanBPM\", \"Dyrk1B\", \"CDK5\", \"Ahi1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"faith_supported":7,"faith_total":7,"faith_pct":100.0}}